SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-056943
Filing Date
2023-10-31
Accepted
2023-10-31 17:00:11
Documents
1
Period of Report
2023-10-27

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4708
  Complete submission text file 0000950170-23-056943.txt   6281
Mailing Address C/O SEELOS THERAPEUTICS, INC. 300 PARK AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address
O'Connor Daniel J. (Reporting) CIK: 0001376847 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-56600 | Film No.: 231365453

Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma, Inc. (Issuer) CIK: 0001990550 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)